lipid_Metabolism,link,pathogenesis,Obj
amyloid_Deposition,is_In,transgenic_Mouse_Model_Of_Alzheimers_Disease,Obj
lipidome_Constitution,consider,lipoprotein-dependent_Alteration,Obj
study_Routine_Laboratory_Test,is_In,twenty_Outpatient_With_Alzheimer_Disease,Obj
four_People,is_With,dementia_Die,Obj
interest,include,cholinesterase_Nft_Tau_Protein_Associate_With_Brain_Cell_Death,Obj
risk,develop,alzheimer_Disease,Obj
marine_Ecosystem,provide,plethora_Of_Pharmacologically_Lead_Molecule_From_Various_Live_Organism,Obj
gene_Expression_Study,affect_By,amyotrophic_Lateral_Sclerosis,Obj
psen1_Associate,is_With,bcr-ck2Î±_Complex,Obj
main_Research_Line,be,study_Of_Metabolite_From_Pathway,Obj
major_Infection,have_Illness_During,surveillance_Period,Obj
participant,perform,significantly_Worse_Than_Control_On_Objective_Cognitive_Measure,Obj
logistical_Challenge,inform,consent_For_Research_Participation_Of_Person,Obj
we,present,main_Molecular_Imaging_Technique_Use_In_Research,Obj
alzheimer,be,multifactorial_Only,Obj
key_Enzyme,involve_In,alzheimers_Disease_Pathogenesis,Obj
increase,is_In,biopsy_Obtain_From_Patient_Diagnose_With_Dementia,Obj
effect,be_Evidence_In,neuroblastoma_Cell,Obj
significant_Overall_Identification_Advantage,be_Show_By,patient_With_Typical_Alzheimer_Disease_Patient_With_Semantic_Progressive_Aphasia,Obj
regenerative_Therapy,is_In,disease_Context,Obj
computer_Aid_Prediction_Model,determine,severity_Of_Alzheimers_Disease_Use,Obj
gr_Signaling,be_Necessary_For,aÎ²o-mediated_Ltp_Impairment,Obj
adult,provide,opportunity_For_Therapeutic_Intervention,Obj
metformin,be,show_Beneficial_In_Several_Other_Condition,Obj
hazard,a-allele_Of,rs9357140,Obj
chelate_Group,show,improvement_In_Inhibition_Of_Cu-induced_AÎ²42_Aggregation,Obj
we,provide,evidence_For_Acute_Functional_Cross-talk_Between_AÎ²_At_Hippocampal_Excitatory_Synaps,Obj
diseasethe_Clinical_Environment,influence,prevalence_Of_Rpd_Cause,Obj
main_Hallmark,be_Presence_Of,amyloid_Plaque_In_Brain_Form_By_Deposition_Of_Insoluble_Amyloid_Protein,Obj
document_Early_Hypopriming,is_In,patient_With_Alzheimers_Disease,Obj
cancer,be,most_Frequent_Scp_Disease,Obj
warrant,dissect,potential_Consequence_Of_Probiotic_Supplementation_In_Course_Of_Alzheimers_Disease,Obj
alzheimer_Disease,be_Devastating,neurodegenerative_Disorder_With_High_Unmet_Medical_Need,Obj
onset,is_In,alzheimers_Disease_Brain,Obj
transplant,is_In,lateral_Ventricle,Obj
aÎ²_Peptide,be,produce_By_Sequential_Cleavage_Of_App_By_Î’-secretase,Obj
somatic_Variant,is_In,autosomal_Dominant_Alzheimers_Disease_Gene,Obj
we,identify,seven_Klc1_Residue_Critical_For_Jip1_Binding,Obj
association,is_In,c9orf72_Patient_At_Cpg_Site_Available_On_Beadchip,Obj
os_Estudo_Selecionado_Foram_Categorizados_Avaliados_Em_Separado_Depender,do,mÃ©todo_De_AnÃ¡lise_OlfatÃ³ria_IdentificaÃ§Ã£o_De_Odores_DiscriminaÃ§Ã£o_Reconhecimento_Uma_Meta-anÃ¡lise_Foi_Realizadacinquenta_Um_Artigos_Foram_Selecionado_Para_AnÃ¡lise,Obj
cognitive_Change,is_In,aging,Obj
discuss,possibility_Of,correct_Neuronal_Ca2_Disruption_As_Therapeutic_Approach_For_Alzheimers_Disease,Obj
mdd_Associate,be_Distinguish_From,mild_Alzheimers_Disease,Obj
everolimus-induced_Mtor_Inhibition,improve,cognitive_Function,Obj
placebo-controlled_Randomize_Clinical_Trial,have_Show,significant_Effect_Of_Acetyl_Cholin_Esterase_Inhibitor_On_Function_Cognition_Activity_Of_Daily_Living_In_Patient,Obj
age-related_Dysregulation,play_Role_In,pathogenesis_Of_Alzheimers_Disease,Obj
wnt_Dysfunction,accelerate,onset_Of_Alzheimers_Disease,Obj
ultrasensitive_Approach_Base,follow_By,deep_Next_Generation_Sequencing_Of_Gene_To_Brain_From_Sporadic_Patient_With_Alzheimers_Disease,Obj
both,be_Hit_For,pelvic_Organ_Prolapse,Obj
inhibition,could_Prevent,deposition_Of_Amyloid_Plaque_In_Neuron,Obj
step,result_From,three_Different_Sample_Preparation_Protocol,Obj
normal_Weight_Obesity,be_Associate_With,increase_Risk_Of_Metabolic_Syndrome,Obj
chronic_Gee_Treatment,decrease,formation_Of_AÎ²_Aggregate,Obj
bacterial_Toxin,may_Lead_To,subsequent_Inflammatory_Process,Obj
vrfcat,be_Suit_For,clinical_Trial_In_Preclinical_Alzheimers_Disease,Obj
age-related_Degeneration,be,lead_Cause_Of_Blindness_In_Industrialised_Country,Obj
age,be,reproducibly_Associate_With_Polymorphism_Within_Kb_Linkage_Disequilibrium_Block_Tag_By_Top-significant_Variation_Rs9357140,Obj
databaseby_September_2017_People,report_Effect_After,take_Flonase,Obj
we,footprint,jip1-binding_Site_On_Klc1-tpr,Obj
age,be_Associate_With,common_Single_Nucleotide_Polymorphism,Obj
poly-ubiquitin_Profile,is_In,alzheimers_Disease_Brain,Obj
risk_Regression_Model,compute,hazard_Ratio,Obj
diagnosis,be,alzheimer_Disease_Frontotemporal_Lobar_Degeneration_Vascular_Dementia,Obj
sex-biased_Epidemiological_Profile,have_Affect_Like,many_Neurological_Disorder_Alzheimers_Disease,Obj
dementia_Associate,is_With,alzheimers_Disease,Obj
brain_Change,is_In,neurodegenerative_Dementia_Start_Accumulate,Obj
we,design,automated_System_For_Determination_Of_Alzheimers_Disease_Severity,Obj
production,involve_In,alzheimers_Disease,Obj
we,analyze,cortical_Thickness,Obj
prospero_Registration_Crd42018089076neurodegenerativa_DoenÃ§a_De_Alzheimer_Um,do,tipo,Obj
irreversible_Neurodegenerative_Disorder,is_With,clinical_Symptom_Of_Progressive_Loss_Of_Cognitive_Function,Obj
drug_Treatment,belong_To,class,Obj
predictor,old_Person_With,coping_Mechanism_Isolation_With_Insufficient_Knowledge_About_Dementia_Poor_Premorbid_Relationship_With_Patient,Obj
mta_Score,be_Associate_With,csf_AÎ²-42,Obj
we,include,case_With_Neuropathologic_Dementia_Diagnosis_From_Department_Of_Pathology_Region,Obj
male,be_More_Frequent_In,population_With_Mean_Age_Respectively,Obj
alzheimer_Disease,be_One,lead_Cause_Of_Death_In_Elderly_People,Obj
we,discover,two_Structurally_Distinct_D1_Receptor_Pam_Mls6585,Obj
consideration,enhance,immune_Status_Of_Body_Inflammation,Obj
blinded_Reader_Radiologist,assess,clinical_Dementia_Expert,Obj
judiciary_System,is_In,general,Obj
priming_Decrement,be_Predict_By,feature_Dominance_Of_Target,Obj
higher_Socioeconomic_Status_Groupsin_Sum_H_Pylori_Seropositivity_Direct_Association,is_With,alzheimers_Disease_Mortality_All-cause_Dementia,Obj
metabolomic,be_Ideal_Approach_For,identification_Of_New_Biomarker,Obj
triacylglycerol_Ceramide_Phosphatidylethanolamine,increase,diacylglycerol,Obj
we,test,maximally_Effective_Concentration_Of_Pam_In_Combination,Obj
sleep,mitigate,functional_Symptom_Of_Neurodegeneration,Obj
identification,represent,one_Important_Challenge_For_Secondary_Prevention_Clinical_Trial_In_Alzheimers_Disease,Obj
study,have_Evaluate,pd-fog,Obj
depression,be,risk_Factor_For_Mild_Cognitive_Impairment,Obj
finding,better_Understand,role_Of_Altered_Protein_O-glcnacylation_Profile_In_Alzheimers_Disease,Obj
anticholinergic_Effect,void,dysfunction_Of_Bph_Patient,Obj
diagnosis,be_Obtain_From,danish_National_Patient,Obj
case,condition_With,disagreement_From_Specialist,Obj
antipsychotic,exacerbate,symptom_Of_Benign_Prostate_Hyperplasia,Obj
recurrence,differ_Among,group_Frontotemporal_Dementia_Patient,Obj
cognitive_Performance,be_Assess_With,memory_Recall_Cognitive_Flexibility,Obj
they_Complex_Function,is_In,human_Most_Protein,Obj
high_Level,state_Of,art_Of_Potential_Influence_Of_Neuropsychiatric_Symptom_On_Caregiver_Stress,Obj
approach,be_Often_Confuse_With,uncertainty,Obj
frequent_Disease,is_In,scp_Patient,Obj
subtypes.this,be,cohort_Study_Of_People_In_Swedish_Dementia_Registry_From_2008-2014,Obj
participant,examine_With,standardized_Neuropsychological_Battery_F-18_Fluorodeoxyglucose_Positron_Emission_Tomography,Obj
programming,is_In,relation_To_Early_Life_Adversity_Enrichmentpotential_Substrate,Obj
we,have_Discuss,role_Of_Nanotechnology_In_Development,Obj
activity,be_Evaluate_As,potential_Human_Acetylcholinesterase_Inhibitor,Obj
memory_Recall,be_Assess_With,rey-osterrieth_Complex_Figure_Task_Cognitive_Flexibility_With_Trail,Obj
17Î²-hsd10,could_Decrease_Respectively,concentration_Of_Two_Important_Neurosteroid_Allopregnanolone,Obj
we,review,recent_Development_In_Design_Against_Alzheimers_Disease,Obj
patient,subsequently_Develop,depression_Anxiety,Obj
alzheimer_Disease_Breakthrough,is_In,biomarker_Identification,Obj
lysosomotropic_Agent_Chloroquine,have,have_Report,Obj
volumetric_Quantification,increase_Accuracy_With,mild_Cognitive_Impairment_However,Obj
we,differentially_Express,transcript_Between_Transgenic_5xfad_Mouse,Obj
alzheimer_Disease,be,lead_Cause_Of_Dementia_In_Older_Adult,Obj
marked_Impairment,is_In,phagocytosis_Of_Apoptotic_Body,Obj
biomarker_Discovery,have,development_For_Clinical_Research_Diagnostic_Monitoring_In_Clinical_Trial,Obj
pre-treatment,with,aqp9_Small_In_Response_To_AÎ²1-40,Obj
alzheimers_Disease_Pathology,be,practically_Irreversible_Application,Obj
vulnerability,is_In,individual_With_Obstructive_Sleep,Obj
risk,be_Investigate_With,cox_Regressionamong_Ap_User_Bph_Medication,Obj
association,remain_In,alzheimers_Disease_Mixed_Dementia,Obj
disturbance,be_Associate_With,alzheimers_Disease_Neurodegeneration,Obj
measurement,be_Use_As,feature_In_We_Algorithm,Obj
aÎ²_Deposit,is_In,vessel_Of_Brain_Of_AÎ²-infused_Non-transplanted_Rat,Obj
consideration,prescribe,medication_With_Anticholinergic_Property,Obj
g4c2-repeat_Expansion,be_Most_Common_Cause_Of,amyotrophic_Lateral_Sclerosis,Obj
infection,be_Also_Implicate_In,many_Chronic_Condition,Obj
grey_Matter,correlate_For,combined_Patient_Cohort,Obj
development,will_Play,increasingly_Important_Role,Obj
stz_Treatment,increase_Percentage_During,normocapnia_Due_To_Reduction_In_Length_Of_Episode_Of_Wakefulness,Obj
minority,is_With,sporadic_Early-onset_Alzheimer_Disease,Obj
series,evaluate_As,potential_Anti_Alzheimer_Disease_Agent,Obj
galanthus_Nivalis_L,be_Know_For,galanthamine_Content_Use_In_Treatment,Obj
tnf-Î±-induced_Phosphorylation,be,significantly_Decrease,Obj
age_Sex,dementia,apoe_Genotype,Obj
hospital-based_Recruitment,provide,basis_For_Increase_Access_To_Acute_Care_Clinical_Research_For_Person_With_Adrd,Obj
disorder,cause,memory_Problem_Independently_Of_Alzheimers_Disease,Obj
infectious_Agent,be_Implicate,pyloriwe_Test_Association_Of_H_Pylori_Seropositivity_With_Incident_All-cause,Obj
we,determine_As,adverse_Event_Report_After_Use_Of_Medicationmachine-readable_Datum_From_Medwatch,Obj
separately.use,risk_Of,initiate_Medication,Obj
alteration,is_With,decrease_Of_Total_O-glcnacylation_Level,Obj
neostigmine,reach,ache_Binding_Site_Report,Obj
we,finding_Shed_Light_On,integration_Of_Smri_With_Rs-fmri_For_Identification_Of_Early_Stage_Of_Alzheimers_Disease,Obj
mri,scan,18f-fdg_Pet_123i-ioflupane-spect_Amyloid-Î²_Pet_Specific_Genetic_Analysis,Obj
ipsc-mglc,secrete,higher_Level_Of_Trem2_Than_Primary_Macrophage,Obj
mosaic_Loss,be_Estimate_From,normalised_Dosage_Of_Genotype_Chip_Datum,Obj
critical_Illness,be,with_Lower_White_Matter_Integrity_Associate_With_Smaller_Brain_Volume_Particularly_Within_Region,Obj
depend,may_Cause,greater_Risk_Suffer_From_Respiratory_Disease,Obj
dyrk1a,emerge_As,potential_Target_For_Prevention_Of_Neuro-degeneration,Obj
alzheimer_Disease,be_Most_Prevalent_Cause_Of,dementia_With_Vascular_Dementia,Obj
enrollment,be,in_Which_Necessity,Obj
good_Antifungal_Activitythe_Result,provide,new_Approach_To_Property,Obj
absolute_10-year_Risk,is_In,woman,Obj
rapid_Cognitive_Decline,is_With,stooped_Posture_Rigidity,Obj
we,understanding_Of,clinical_Evaluation_Of_Alzheimers_Disease,Obj
overall_Diagnostic_Accuracy,recruit,optimal_Candidate_For_Future_Therapeutic_Trial,Obj
study,have_Show,comparable_Effect_For_Chei_In_Patient_With_Moderate-to-severe,Obj
alzheimer_Disease,be,most_Common_Cause_Of_Dementia_In_Elderly_Characterize_By_Progressive_Cognitive_Dysfunction,Obj
frontotemporal_Dementia_Patient,have,relatively_Higher_Prevalence_Of_Pi,Obj
clinical_Study,have_Yield,inconsistent_Finding_On_Effect_Of_Vitamin_On_Alzheimers_Disease_Risk,Obj
we,propose,formal_Definition_Of_Dementia_Case-finding_With_Clear_Distinction_From_Screening,Obj
amyloid_Plaque,affect,endoplasmic_Reticulum-mitochondria_Apposition,Obj
advancement,ease,process_Of_Cultivation_Of_Microbe_Isolation_Of_Novel_Bioactive_Metabolite_Of_Clinical_Use,Obj
comprehensive_Lipid_Profiling,is_In,different_Lipoprotein_Level_Of_Patient_Plasma_With_Alzheimers_Disease,Obj
ability,image,in_Pathological_Substrate_Of_Degenerative_Disease,Obj
we,spectrum_Of,atypical_Early_Manifestation_Of_Cjd,Obj
freezing,be,disable_Phenomenon,Obj
identification_Susceptible,improve,they_Clinical_Management,Obj
lumbar_Puncture,exclude,condition_Of_Neuroborreliosis,Obj
psen1_Deficiency,is_In,mouse_Endothelial_Cell_Show,Obj
neurogranin_Bace1_Ratio,can_Distinguish_Between,depression_Among_Patient_With_Similar_Cognitive_Deficit,Obj
molecular_Mechanism,include,apoptosis_Oxidative_Shock_Inflammation_Immune_Activation,Obj
clinical_Trial,require,measure_With_Increase_Sensitivity_To_Subtle_Deficit_In_Instrumental_Activity,Obj
age-associated_Decrease,is_In,hippocampus_Of_Appswe_Ps1de9_Alzheimers_Disease_Mouse,Obj
little,know_About,inph,Obj
promise,is_In,other_Neurological_Disorder_Such_Huntington_Disease,Obj
pooled_Hazard_Ratio,be_For,prevalent_Stroke,Obj
dlb_Patient,be_Divide_Into,pure_Dlb,Obj
kynurenic_Acid_Production,administration_Of,ad-associated_Amyloid-Î²42_Cause_Classical_Neuropathology,Obj
future_Application,be_In,validation_Of_Further_Target,Obj
we,administer_Sp_Attribute_Condition_Paradigm_To,mildly_Demented_Patient_With_Alzheimers_Disease,Obj
we,review_On,current_Status_Of_Research_In_Development_Of_Dyrk1a_Inhibitor,Obj
association,is_With,cognitive_Impairment,Obj
older_Age,predict,higher_Odds_Of_Amnestic_Alzheimer_Disease_Dementia,Obj
several_Hypothesis,explain,early_Mechanism_Of_Alzheimers_Disease_Pathogenesis,Obj
patient,diagnose_With,probable_Behavioral-frontotemporal_Dementia,Obj
mean_Mental_State_Examination_Score,be,7.7,Obj
phenotype_Analysis,detect_Association_In,only_Largest_Subgroup_Of_Patient_With_Frontotemporal_Dementia,Obj
we,investigate,possible_Link_Between_Bacterial_Infestation_Of_Oral_Cavity_Dental_Health,Obj
may_Potential_Experimental_Model,relate_To,pathogenesis_Of_Sad,Obj
cohort,affect_By,frontotemporal_Dementia,Obj
alzheimers_Disease,have,have_Clinical-pathologic_Diagnosis,Obj
intervention,is_In,alzheimers_Disease,Obj
method,save_Of,unnecessary_Csf_Pet_Test,Obj
psen1_Overexpression,conversely_Enhance,reporter_Activation_Under_Nf-Îºb_Responsive_Element,Obj
whose_Alteration,may_Contribute_To,insulin_Resistance,Obj
pet_Scan_Analysis,demonstrate,early_Reduction_Of_Cerebral_Glucose_Metabolism,Obj
two_Reliable_Assay,identify,first_Generation_Of_Steroidal_Inhibitor_Of_Pure_17Î²-hsd10,Obj
multistage_Approach,therefore_Be_Need,development_Of_Initial_Screen,Obj
global_Atrophy_Score,be_Comparable_Between,dementia_Group,Obj
alzheimer_Disease,be,most_Common_Cause_Of_Dementia_Worldwide_With_Prevalence_Continue,Obj
alzheimer_Disease,be,neurodegenerative_Disorder_Characterize_By_Progressive_Loss_Of_Memory_Reasoning,Obj
short-term_Treatment,is_With,everolimus,Obj
montreal_Cognitive_Assessment_Scale_Hamilton_Rating_Scale,assess,cognitive_Function,Obj
use,be_Associate_With,increase_Risk_Of_Initiate_Medication_For_Bph_In_Man_With_Alzheimer_Disease,Obj
treatment_Method,represent,major_Deficiency_For_Therapeutic_Necessity,Obj
recommendation,overcome,they,Obj
alzheimers_Disease_Animal_Present_Increase_Sensitivity,sleep,disruption,Obj
design,identify,novel_Alzheimers_Disease_Drug_Target_Gene,Obj
molecular_Network,encode,molecular_Mechanism_Of_Biological_Process_Development,Obj
possible_Protective_Role,is_In,preclinical_Alzheimer_Disease,Obj
promising_Strategy,is_In,conclusion_Dementia_Case-finding,Obj
alzheimer_Disease,be,progressive_Neurodegenerative_Disorder,Obj
compare,processing_In,patient_With_Primary_Progressive_Aphasia_Patient_With_Typical_Alzheimer_Disease,Obj
alzheimer_Disease,be,complex_Disease_Drive_Mainly_By_Neuronal_Loss_Due_To_Accumulation_Of_Intracellular_Neurofibrillary_Tangle_In_Brain,Obj
we,profile_Transcriptome_During,early_Stage_Of_Disease_Development,Obj
psen1_Function,include,could_Novel_Therapeutic_Target_For_Various_Chronic_Inflammation_Condition,Obj
mci-c,achieve,accuracy_Of_For_Smri_For_Rs-fmri,Obj
rapamycin_Inhibition_Increase_Lifespan,is_In,mouse,Obj
association,be_Perturb_In,absence_Of_Psen1,Obj
alzheimers_Disease_Change,contribute,important_Element,Obj
alzheimer_Disease,be_Characterize_By,loss_Of_Neuron,Obj
spp1,provide,valuable_Research_Tool,Obj
more_Devastating_Disease_Course,is_In,dlb_Alzheimers_Disease_Patient,Obj
fucosterol,reach,acetylcholinesterase_Binding_Site,Obj
search,be_Major_Concern_In,light_Of_Today_Age_Population,Obj
brain_Cell,be_Link_To,neurodegeneration,Obj
participant,be_Classify_At,visit_Base_On_Specific_Feature_Of_They,Obj
intrathecal_Infusion,treat,early_Stage_Of_Ad-pathology,Obj
vitamin_Level,be_Genetically_Associate_With,alzheimers_Disease_Risk,Obj
evidence,emphasize,interaction_Among_Ethnicity_Genetics_Epigenetic_Environment_Culture_In_Influence_Manifestation_Of_Dementia,Obj
it,be,common_Cause_Of_Fall_In_Case_With_Parkinsons_Disease,Obj
risk_Factor,assess,stroke,Obj
alzheimers_Disease_Preclinical_Alzheimers_Disease,identify,oxidatively_Modify_In_Animal_Model_Of_Alzheimers_Disease,Obj
homozygous_Missense_Mutation,is_In,trem2_Cause_Nasu-hakola_Disease_Early-onset_Dementia,Obj
people,is_With,alzheimer_Disease,Obj
alzheimers_Disease_Epidemic_Identification,occur_Across,entire_Life_Spectrum_Of_Human,Obj
dementia,is_In,different_Region_Of_Worlda_Critical_Review_Of_Limited_Literature_From_Global_South_Compare_With_Advance,Obj
we,present,summary_Of_Protective_Bioactivity_Of_Docosanoid_In_Experimental_Ischemic_Stroke,Obj
one_Compound_Androstane_Derivative,possess,best_Dual_Inhibition_Against_Transformation,Obj
search,be,pivotal,Obj
unprecedented_Research_Growth,is_In,area_Of_Nanotechnology,Obj
new_Diagnostic_Approach,is_In,particularly_Easily-accessible_Biofluid,Obj
proteostasis,is_In,check,Obj
place_Npd1_Protection,elicit_By,dha,Obj
we,classify,subject_With_Depression_Into_Amyloid-Î²-positive_Group,Obj
potential_Alzheimers_Disease_Drug_Target_Gene,integrate,information_Of_Multiple_Popular_Database,Obj
it,be_Cause_Of,dementia_In_Elderly_Population,Obj
longitudinal_Study,is_With,more_Participant,Obj
31b,additionally_Inhibit,dyrk1a_In_Intact_Cell_With_High_Efficacy,Obj
important_Step,develop,approach_To_Early_Treatment,Obj
literature_Search,identify,study_Use_Neuropsychological_Evaluation,Obj
several_Mitochondria_Contact_Site,include,mercs_In_Human_Brain_Biopsy,Obj
decrease_Tau_Hyperphosphorylation,induce_In,transgenic_Alzheimers_Disease_Mouse_Model,Obj
in_Spp1,be_Potent_Agonist_Of,cortical_M1_Receptor_With_Activity_Conserve_Across_Species,Obj
trem2_Expression,be_Reduce_In,variant_Line,Obj
d1_Dopamine_Receptor,represent,attractive_Drug_Target_For_Enhancement_Of_Cognition_In_Schizophrenia_Alzheimer_Disease,Obj
they,result,relate_To_Infection,Obj
component,describe,cause_Of_Cognitive_Change_In_Aging,Obj
attend,be,of_They_Include_In_Icp,Obj
everolimus,show,higher_Stability_Than_Rapamycin,Obj
drug_Development,be_Hamper_By,limited_Understanding_Of_Disease,Obj
critical_Illness,be_Associate_In,hospitalize_Participant,Obj
extensive_Clinical_Investigation,be,conduct_At_Department_Of_Geriatric_Psychiatry_In_Lundof_Patient_Study,Obj
we,analyze,behavioral_Phenotype,Obj
comorbidity,include,alzheimers_Disease_Pathological_Hallmark,Obj
it,be_Likely_In,alzheimers_Disease_Pathology,Obj
neurobiology,is_In,neurodegenerative_Disease,Obj
association,is_With,mood_Disorder_Depression,Obj
idiopathic_Normal_Pressure_Hydrocephalus,be,neuropathology,Obj
wnt_Signaling,be_Fundamental_In,amyloid_Precursor_Protein_Processing,Obj
sleep_Apnea,be,risk_Factor_For_Dementia,Obj
we,identify,spiropiperidine_Spp1,Obj
enrichment_Analysis,explore,function_Of_Identify_Potential_Drug_Target_Geneseighteen_Potential_Drug_Target_Gene,Obj
cognitive_Impairment,is_In,older_Adult,Obj
biomarker,analyze,gut_Inflammation_Marker_In_Fecal_Specimen,Obj
certain_Neurodegenerative_Disease,be,explicitly_Link,Obj
o-glcnacylation,have,have_Report_In_Alzheimers_Disease,Obj
we,measure_Ventilation_Electroencephalography_During,normocapnia_Hypercapnia_In_Wistar_Rat,Obj
she,present_Work_On,role_Of_Virus_Specifically_Hsv-1_In_Pathogenesis_Of_Alzheimers_Disease,Obj
it,be,when_Operationally_Define,Obj
therapy,potential_Role_Of,computer_Drive_Artificial_Intelligence_Approach,Obj
key_Responsible_Event,include,formation_Of_Î’-amyloid_Protein_Clustering_To_Amyloid_Plaque_On_Blood_Vessel,Obj
potential_Effect_Modifierswe,identify,study_Of_Prevalent_Stroke_Of_Incident_Stroke,Obj
chronic_Infection,is_In,brain_Tissue,Obj
maximum_Velocity,km,constant_Of_Michaelis-menten_Estimate_For_Fucosterol,Obj
significant_Rqtl,be_Screen_For,interaction_With_Other_Locus_For_Trait_In_Rqtl_Model,Obj
alzheimer_Disease,be_Associate_With,energy_Metabolism_Deficiency,Obj
absolute_Risk,obtain_Datum_From,copenhagen_General_Population_Study,Obj
novel_Nucleotide_Substitution,is_In,exon_Of_Psen1_Gene,Obj
typical_Cognitive_Decline_Patient,develop,disorder_Of_Respiratory_System,Obj
cellular_Calcium_Signal,regulate,important_Facet_Of_Neuronal_Physiology,Obj
diagnostic_Confidence_Increase,identify,mci_Patient_With_Alzheimers_Disease,Obj
they,overall_Show,good_Activity_For_Ache_Inhibition,Obj
we,investigate,association_Of_Circulate_Vitamin_Level_With_Alzheimers_Disease_Use_Large-scale_Vitamin_Genome-wide_Association_Study_Data_Set,Obj
use_Approach,include,network_Topological_Analysis_Identification_Of_Novel_Pathway_Drug_Target,Obj
clinician,syndrome_Such_As,mild_Cognitive_Impairment_As_Probable_Alzheimers_Disease_Since_Diagnosis_Of_Definite_Alzheimers_Disease,Obj
sensory_Disturbance_Seizure_Isolate_Psychiatric_Manifestation,mimic,stroke_Isolate,Obj
mloy,be_Associate_With,late-stage_Amd_With_Genome-wide_Significance_Independent_Of_Age,Obj
changed_Regional_Cerebral_Blood_Flow,is_In,mild_Cognitive_Impairment,Obj
such_Tool,be,implement_In_Routine_Diagnostic_Work-up_Of_Patient_With_Suspect_Alzheimers_Disease,Obj
point_Mutation,abrogate,mls1082_Activity,Obj
participant,undergo,questionnaire_Physical_Examination,Obj
patient_Participant,is_With,scd_Namci,Obj
we,capture_Modulation_In,subject_With_Alzheimers_Disease,Obj
promising_Therapeutic_Approach,include,huntingtin_Lowering,Obj
cognitive_Impairment,is_In,late-life_Depression,Obj
validation,have_Lead_To,advancement_Of_Pharmacological_Agent,Obj
accumulation,be_Associate_With,alzheimers_Disease,Obj
we,characterize,interaction_Between_Klc1,Obj
we,apply_Class_Analysis_To,baseline_Neuropsychological_Assessment_For_Participant_From_Einstein_Aging_Study,Obj
begin,prior_To,birth_In_Most_Dreaded_Disease_Of_Society,Obj
prof_FÃ¼lÃ¶p,describe,role_Of_Ad-associated_Amyloid_Beta_Peptide_As_Antibacterial_Antifungal,Obj
class,be_Identify,mixed-domain_Impairment_Memory-specific_Impairment_Average_Frontal_Impairment,Obj
17Î²-hydroxysteroid_Dehydrogenase_Type,be,mitochondrial_Enzyme_Know_For_Its_Potential_Role_In_Alzheimers_Disease,Obj
frontal_Impairment_Class,be_Associate_With,higher_Risk,Obj
brain_Protein,be_Increasingly_Polyubiquitinate_In,alzheimers_Disease_Human_Brain_Compare_To_Age-matched_Control,Obj
jip1,be_Identify_As,scaffold_Protein_For_Map_Kinase_Jnk,Obj
cognitive_Impairment_Tau_Phosphorylation,is_In,hippocampus_Of_Wild-type_Mouse,Obj
virtual_Reality_Capacity_Assessment_Tool_Assessment,make,test_Part_Bparticipants,Obj
identification,mediate_By,dha-synthesized_Elv,Obj
breakthrough,explore,such_Marine_Natural_Resource_For_Pharmacological_Lead_Molecule,Obj
mouse,finally_Be_Treat_With,continuous_Infusion_Of_Vehicle,Obj
development,intend_For,use_In_Preclinical_Population,Obj
several_Key_Property,compound,suitable_For_Future_In_Study,Obj
relationship_Quantitative_Trait_Locus,be_Often_Involve_In,gene-by-gene_Interaction,Obj
treatment,be_Currently_Target_Toward,symptomatic_Therapy,Obj
development,have,however_Have_Thus_Far_Slow,Obj
semantic_Memory_Degradation,is_In,alzheimers_Disease_Pathology,Obj
mutation,be_Common_Cause_Of,autosomal_Dominant_Alzheimer_Disease,Obj
important_Role,is_In,aÎ²-induced_Pathogenesis_Of_Alzheimers_Disease,Obj
diagnosis.databases,be,for_Complement_Search_Relate_To_Proposed_Theme,Obj
neuropsychiatric_Symptom,be,more_Closely_Related,Obj
datum,lead_To,identification_Of_Several_Protein,Obj
promising_Result,is_In,diagnosis_Of_Alzheimers_Disease,Obj
alzheimers_Disease_Group,reduce,priming_Facilitation,Obj
crispr_Cas9_Gene_Editing,can,can_Use_As_Direct_Treatment_Approach,Obj
glucocorticoid_Receptor,participate_In,aÎ²Î¿_Generation,Obj
several_Glycine_Alanine_Substitution,reveal,aggressive_Alzheimer_Disease_Phenotype_Psen1_Gly417ala,Obj
micrornas,relate_To,common_Network_With_Amyloid_Precursor_Protein,Obj
we,observe,that_Stz_Injection_Cause_Cognitive_Impairment_In_Animal_Temporal_Variation_Of_Insulin_Signaling-related_Protein_In_Hippocampus,Obj
clinical_Evaluation,promote,detection_Of_Common_Cause_Of_Rpd_Specific_To_Practice_Setting,Obj
accumulation,can,can_Associate_With_Impairment_Of_Degradative_System,Obj
energetic_Difference,is_In,binding_Interaction_From_Fucosterol_With_Ache,Obj
molecular_Imaging_Technique_Use_18f-fluorodeoxyglucose_Amyloid_Tracer,improve,more_Recently_Tau_Ligand,Obj
strong_Correlation,is_With,degree_Of_Brain_Atrophy,Obj
enormous_Global_Health_Burden,is_In,term_Of_Human_Suffering,Obj
we,herein_Describe,design_Of_Series_Of_Amide_Functionalize_24-bispyridyl_Thiophene_Compound_Of_Which,Obj
nonvalidated_Clinical_Algorithm,be_Propose_For,earlier_Identification_Of_Complex_Atypical_Neurodegenerative_Disease,Obj
good_Efficacy,improve,cognitive_Function_In_Alzheimers_Disease_Patient,Obj
measure_Sensitivity_Validate_Use,is_With,subjective_Cognitive_Declinecross-sectional_Validation_Studyall_Participant,Obj
year,have_Stand_To,profound_Discovery_About_Nature_Of_Disease,Obj
patient,have,additional_Loss_Of_Gray_Matter_Volume,Obj
three_Present_Comorbidity,is_With,other_Dementia,Obj
framework,use,national_Institutes_Of_Health_National_Institute_Of_General_Medical_Science_Center_Of_Biomedical_Research_Excellence_Grant_Mechanism,Obj
discuss,evidence_For,best_Practice_At_Stage_With_Recommendation_For_Research,Obj
patient,be_Characterize_By,deposition_Of_Senile_Plaque_Form,Obj
some,be_Due_To,interaction_With_Other_Locus,Obj
cdap_Group,reduce,rcmglc_Predominantly_In_Temporoparietal_Region,Obj
correlation,vary_By,genotype,Obj
low_Dose,have,have_Use_As_Experimental_Model_Of,Obj
pronounced_Medial_Temporal_Lobe_Atrophy,dlb,alzheimers_Disease,Obj
steroidal_Inhibitor,be,of_Different_Parameter_Analog_Of_First_Report_Screen,Obj
alzheimer_Disease,be_Characterize_By,accumulation_Of_Amyloid_Plaque_In_Brain,Obj
amyloid-Î²_Accumulation,be_Hallmark_Of,alzheimers_Disease,Obj
this,have_Enable,specific_About_Underlie_Cause,Obj
nine_Somatic_Variant,sequencingtwo_Of,sorl1_Variant,Obj
animal,is_With,intracerebroventricular_Streptozotocin_Drug,Obj
neuroanatomical_Association,be_Assess,use_Voxel-based_Morphometrypatients_With_Non-fluent,Obj
we,have_Develop_Ship2_Inhibitor_By,extensive_Structural_Elaboration_Of_Crizotinib,Obj
reliable_Way,predict,development_Of_Alzheimer_Disease_Among_Patient_With_Mild_Cognitive_Impairment,Obj
stress,occur_In,early_Alzheimers_Disease_Pathogenesis_In_Altered_Antioxidant,Obj
available_Treatment_Result,is_In,symptomatic_Relief,Obj
aim,investigate,prevalence_Of_Police_Interaction,Obj
biological_Mechanism,relevance_Of,neuronal_Vulnerability,Obj
strong_Rqtl,ptau_AÎ²42_Rqtl_With,alzheimers_Disease_Case_Control_Status_Rs1036819,Obj
tamanho,do,efeito_Da_Maioria_Dos_Estudos_Foi_Grande_Assim_Como_Os_Valores_SumÃ¡rios_De_Cada_Categoria_De_AnÃ¡lise_OlfatÃ³riaentre_Os_DomÃ­nios_OlfatÃ³rios_Excetuando_MemÃ³ria_IdentificaÃ§Ã£o_Parece_Ser_Mais_Alterada_Em_Da,Obj
alzheimers_Disease,encompass,continuum_Span_From_Preclinical_Through_Symptomatic_Predementia,Obj
case,diagnose_With,borreliosis,Obj
some,affect,risk_Of_Alzheimers_Disease,Obj
association,occur_During,middle_In_Older_Adultsprospective_Cohort_Studyatherosclerosis_Risk_In_Community_Studya_Community_Sample,Obj
neurodegenerative_Dementia,constitute,broad_Group,Obj
potential_Adaptation,chemically_Synthesize_With,well-defined_Shape_Size_Reminiscent_For_Treatment_Of_Disease,Obj
interleukin-4,restore,nsc_Proliferative_Ability,Obj
dementia,be,major_Cause,Obj
they_Plasticity,is_In,alzheimers_Disease,Obj
people,be,more_Frequently_Include,Obj
2017_People,report_Effect_After,take_Lipitor,Obj
crucial_Residue,involve_In,molecular_Recognition_Of_Ligand_By_Ache,Obj
alzheimers_Disease_Management,require,shift_From_Prevail,Obj
sequence_Search,is_In,eukaryotic_Genome,Obj
caregiver_Burden,worsen,relationship_Between_Caregiver_With_Alzheimers_Disease,Obj
supplementation,is_With,multispecy_Probiotic_Influence_Gut_Bacterium_Composition,Obj
stem_Cell_Transplantation,improve,neurological_Performance_In_Neurodegenerative_Disease,Obj
mls1082,may_Serve,as_Important_Tool_Compound_For_Characterization_Of_Diverse_Allosteric_Site_On_D1_Receptor,Obj
neurological_Performance,is_In,aÎ²-infused_Alzheimers_Disease_Model_Rat,Obj
we,investigate,effect_Of_Chronic_Consumption_Of_Guarana_Ethanolic_Extract_On_AÎ²_Toxicity_Use_C_Elegan_Model_Of_Alzheimers_Disease,Obj
study,elucidate,lipoprotein-dependent_Alteration_Of_Lipid_In_Progression_Of_Mci,Obj
protein_Kinase_Dyrk1a,modulate,several_Process_Relevant_To_Development_Of_Alzheimers_Disease_E_G,Obj
dementia,is_In,older_Population,Obj
molecular_Pathology,is_In,female_Use,Obj
we,assess,association_Of_Mloy_On_Amd_Risk_In_Male_Case,Obj
anticholinergic_Burden,be,associate_With_Poorer_Cognitive_In_People_With_Dementia,Obj
alzheimer_Disease,be,progressive_Neurodegenerative_Disorder_Associate_With_Aging,Obj
we,assess,whether_Sleep_Moderate_Relationship_Between_AÎ²_In_Older_Adult_Mean_Age_Year,Obj
we,apply,ligand-based_Pharmacophore_Modeling_Approach_Couple,Obj
we,here_Report,qsp_Model_For_Alzheimers_Disease_With_Particular_Focus,Obj
we,propose,evidence_Requirement_For_Implementation_In_Clinical_Practice,Obj
new_Approach,inhibit,aÎ²42_Fibril_Formation,Obj
environment,affect,mental_Health,Obj
wnt_Signaling_Activation,be_Propose_As,neuroprotective_Mechanism_Against_AÎ²_Toxicity,Obj
less_Hypertension,result,likewise_Significantly_Less_Dm,Obj
partial_M1_Orthosteric_Agonist,identify_Of,spp1_Novel_Functionally_Selective_Brain_Penetrant,Obj
importance,is_In,onset_Of_Alzheimers_Disease,Obj
foster_Improvement,is_In,delivery_Of_High-quality_Care_To_Person_With_Adrd,Obj
regional_Cerebral_Glucose_Metabolism,is_In,older_Adult_With_Depression,Obj
introduction,significantly_Increase,potential_For_Diagnosis_Of_Creutzfeldt-jakob_Disease,Obj
experiment,be_Challenge_Because_Of,mainly_High_Aggregation_Tendency_Of_AÃŸ,Obj
aÎ²o-mediated_Psd95_Increase,gr_With,two_Different_Gr_Antagonist,Obj
specific_Protein_Target,is_In,brain_Of_12-month-old_Tg-ad_Mouse,Obj
pre-treatment,is_With,extracellular_Soluble_Form_Of_Two_Peptide,Obj
surface_Mutation_F19s,reduce,l34p,Obj
subject,be_Recruit_Into,late-life_Depression_With_Cognitive_Impairment,Obj
subset,undergo,3-tesla_Brain_Magnetic_Resonance_Imaging,Obj
female_Sex_Median_Patient_Age,be_Consistent_With,clinic_Demographic,Obj
goal,develop_M1_Receptor_Agonist_As,potential_Therapeutics_For_Symptomatic_Treatment,Obj
community-dwelling_Person,diagnose_With,alzheimers_Disease,Obj
along,differ_Between,moderate_Alzheimers_Disease,Obj
we,consistently_Observe,dose-dependent_Downregulation_Of_Aqp9_Expression_In_Pc12_Cell_After_Treatment_With_Amyloid-beta_Protein_1-40,Obj
we,also_Examine,role_Of_Each_Of_Critical_Residue_Of_Klc1_For_Jip1_Binding_In_Light_Of_Previously_Report_Crystal_Structure_Of_Klc1-tpr_Jip1_Complex,Obj
prof_Balin,describe,involvement_Of_Brain_Tissue_Infection_By_Chlamydia_Pneumoniae_Bacterium_With_Its_Potential,Obj
aim,evaluate,beginning_Of_Alteration_In_Brain_Ir_Pathway_Of_Rat,Obj
allosteric_Modulator,may_Represent,viable_Drug_Development_Strategy,Obj
dpph_Radical_Scavenging_Frap_Hemoglobin_Ascorbate_Peroxidase_Activity_Inhibition_Inhibition,catalyze_By,cytochrome,Obj
